PFIZER ApS
CVR: 66351912
Secondary names: PHARMACIA ApS, ACO ApS, KABI PHARMACIA ApS
The financial health of PFIZER ApS shows signs of decline, with a significant drop in revenue from 2.3 billion DKK in 2022 to 847 million DKK in 2024, alongside a decrease in profit from 92 million DKK to 13 million DKK during the same period. Equity has also fluctuated, increasing slightly to 368 million DKK in 2024 but down from a peak of 483 million DKK in 2021. The declining revenue and profit margins raise concerns about the company's sustainability and competitive position within the pharmaceutical wholesale industry. Despite its previous strong performance, the current trajectory suggests challenges ahead that may impact its market standing.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive virksomhed indenfor handel og industri.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 847.5 mio. | 13.1 mio. | 637.9 mio. | 368.1 mio. | 105 | |
History
Ownership
Management
Directors
Board
Production units (3)
Similar companies
Companies in the same industry and area